Tag: LILLY DRN

Danish drugmaker Novo Nordisk presented its annual report in Bagsvaerd, Denmark, showcasing flags with the company's logos, including those of ...

Novo Nordisk defended disappointing trial results for its obesity drug candidate CagriSema, emphasizing its importance as a weight loss treatment ...

Danish drugmaker Novo Nordisk showcased flags featuring the logos of their popular diabetes and weight-loss treatments Ozempic and Wegovy during ...

Novo Nordisk's hopes of revolutionizing obesity treatment with its CagriSema drug have been cast into doubt following disappointing trial results, ...

Roche has agreed to a $5.3 billion deal with Zealand Pharma to develop the obesity drug candidate petrelintide, including a ...

The White House downplayed the recent stock market sell-off, attributing it to "animal spirits" rather than economic fundamentals, despite concerns ...

Shares of Novo Nordisk rose 4.5% after reporting a better-than-expected net profit in the fourth quarter, driven by strong demand ...

Pharmaceutical companies are optimistic about growth under the Trump administration, with hopes for a pro-business approach focusing on cracking down ...

Shares of Novo Nordisk surged 10% following positive early-stage results for its once weekly amycretin obesity drug, which led to ...

Jamie Dimon, CEO of JPMorgan Chase & Co., spoke at the IIF during the annual IMF and World Bank meetings ...